Search Results - "Berhane, Sarah"

Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials by Jackson, Richard, Psarelli, Eftychia-Eirini, Berhane, Sarah, Khan, Harun, Johnson, Philip

“…Purpose Following the Sorafenib Hepatocellular Carcinoma Assessment Randomized Protocol (SHARP) trial, sorafenib has become the standard of care for patients…”
Get full text

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection by Dinnes, Jacqueline, Deeks, Jonathan J, Adriano, Ada, Berhane, Sarah, Davenport, Clare, Dittrich, Sabine, Emperador, Devy, Takwoingi, Yemisi, Cunningham, Jane, Beese, Sophie, Dretzke, Janine, Ferrante di Ruffano, Lavinia, Harris, Isobel M, Price, Malcolm J, Taylor-Phillips, Sian, Hooft, Lotty, Leeflang, Mariska Mg, Spijker, René, Van den Bruel, Ann

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting COVID-19 pandemic present important diagnostic challenges. Several diagnostic…”
Get more information

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection by Chan, Anthony W.H., Zhong, Jianhong, Berhane, Sarah, Toyoda, Hidenori, Cucchetti, Alessandro, Shi, KeQing, Tada, Toshifumi, Chong, Charing C.N., Xiang, Bang-De, Li, Le-Qun, Lai, Paul B.S., Mazzaferro, Vincenzo, García-Fiñana, Marta, Kudo, Masatoshi, Kumada, Takashi, Roayaie, Sasan, Johnson, Philip J.

“…[Display omitted] •Recurrence is frequent within 2 years of surgical resection of hepatocellular carcinoma.•In this large collaboration, we identify readily…”
Get full text

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection by Dinnes, Jacqueline, Sharma, Pawana, Berhane, Sarah, van Wyk, Susanna S, Nyaaba, Nicholas, Domen, Julie, Taylor, Melissa, Cunningham, Jane, Davenport, Clare, Dittrich, Sabine, Emperador, Devy, Hooft, Lotty, Leeflang, Mariska Mg, McInnes, Matthew Df, Spijker, René, Verbakel, Jan Y, Takwoingi, Yemisi, Taylor-Phillips, Sian, Van den Bruel, Ann, Deeks, Jonathan J

“…Accurate rapid diagnostic tests for SARS-CoV-2 infection would be a useful tool to help manage the COVID-19 pandemic. Testing strategies that use rapid antigen…”
Get more information

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients by Berhane, Sarah, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Kagebayashi, Chiaki, Satomura, Shinji, Schweitzer, Nora, Vogel, Arndt, Manns, Michael P, Benckert, Julia, Berg, Thomas, Ebker, Maria, Best, Jan, Dechêne, Alexander, Gerken, Guido, Schlaak, Joerg F, Weinmann, Arndt, Wörns, Marcus A, Galle, Peter, Yeo, Winnie, Mo, Frankie, Chan, Stephen L, Reeves, Helen, Cox, Trevor, Johnson, Philip

“…Background & Aims GALAD and BALAD-2 are statistical models for estimating the likelihood of the presence of hepatocellular carcinoma (HCC) in individual…”
Get full text

The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers by JOHNSON, Philip J, PIRRIE, Sarah J, HUSSAIN, Syed, GRAHAM, Janine, REEVES, Helen, SATOMURA, Shinji, COX, Trevor F, BERHANE, Sarah, TENG, Mabel, PALMER, Daniel, MORSE, Janet, HULL, Diana, PATMAN, Gillian, KAGEBAYASHI, Chiaki

“…Hepatocellular carcinoma is a common complication of chronic liver disease (CLD), and is conventionally diagnosed by radiological means. We aimed to build a…”
Get full text

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade by Toyoda, Hidenori, Lai, Paul BS, O'Beirne, James, Chong, Charing C, Berhane, Sarah, Reeves, Helen, Manas, Derek, Fox, Richard P, Yeo, Winnie, Mo, Frankie, Chan, Anthony WH, Tada, Toshifumi, Iñarrairaegui, Mercedes, Vogel, Arndt, Schweitzer, Nora, Chan, Stephen L, Sangro, Bruno, Kumada, Takashi, Johnson, Philip J

“…Background: Application of curative therapy for hepatocellular carcinoma is crucially dependent on underlying liver function. Using the recently described ALBI…”
Get full text

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion by Waked, Imam, Berhane, Sarah, Toyoda, Hidenori, Chan, Stephen L, Stern, Nicholas, Palmer, Daniel, Tada, Toshifumi, Yeo, Winnie, Mo, Frankie, Bettinger, Dominik, Kirstein, Martha M, Iñarrairaegui, Mercedes, Gomaa, Asmaa, Vogel, Arndt, Meyer, Tim, Sangro, Bruno, Lai, Paul, Kumada, Takashi, Johnson, Philip J

“…Background: Transarterial chemo-embolisation (TACE) is recommended for patients with BCLC intermediate stage hepatocellular carcinoma (stage B), particularly…”
Get full text

Diagnostic Models Combining Clinical Information, Ultrasound and Biochemical Markers for Ovarian Cancer: Cochrane Systematic Review and Meta-Analysis by Davenport, Clare F, Rai, Nirmala, Sharma, Pawana, Deeks, Jon, Berhane, Sarah, Mallett, Sue, Saha, Pratyusha, Solanki, Rita, Bayliss, Susan, Snell, Kym, Sundar, Sudha

“…Background: Ovarian cancer (OC) is a diagnostic challenge, with the majority diagnosed at late stages. Existing systematic reviews of diagnostic models either…”
Get full text

Information given by websites selling home self-sampling COVID-19 tests: an analysis of accuracy and completeness by Taylor-Phillips, Sian, Berhane, Sarah, Sitch, Alice J, Freeman, Karoline, Price, Malcolm James, Davenport, Clare, Geppert, Julia, Harris, Isobel M, Osokogu, Osemeke, Skrybant, Magdalena, Deeks, Jonathan J

“…ObjectivesTo assess the accuracy and completeness of information provided by websites selling home self-sampling and testing kits for…”
Get full text

Risk estimation for biliary tract cancer: Development and validation of a prognostic score by Schweitzer, Nora, Fischer, Mareike, Kirstein, Martha M., Berhane, Sarah, Kottas, Martina, Sinn, Marianne, Gonzalez‐Carmona, Maria A., Balta, Zeynep, Weismüller, Tobias J., Strassburg, Christian P., Reineke‐Plaaß, Tanja, Bektas, Hüseyin, Manns, Michael P., Johnson, Philip, Weinmann, Arndt, Vogel, Arndt

“…Background & Aims Biliary tract cancer is a rare tumour entity characterized by a poor prognosis. We aimed to identify prognostic factors and create a…”
Get full text

THU499 - Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma by Johnson, Philip, Berhane, Sarah, Kolamunnage-Dona, Ruwanthi

Get full text

Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma by Johnson, Philip, Berhane, Sarah, Kolamunnage-Dona, Ruwanthi

Get full text

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade by Johnson, Philip J, Berhane, Sarah, Kagebayashi, Chiaki, Satomura, Shinji, Teng, Mabel, Reeves, Helen L, O'Beirne, James, Fox, Richard, Skowronska, Anna, Palmer, Daniel, Yeo, Winnie, Mo, Frankie, Lai, Paul, Iñarrairaegui, Mercedes, Chan, Stephen L, Sangro, Bruno, Miksad, Rebecca, Tada, Toshifumi, Kumada, Takashi, Toyoda, Hidenori

“…Most patients with hepatocellular carcinoma (HCC) have associated chronic liver disease, the severity of which is currently assessed by the Child-Pugh (C-P)…”
Get full text

The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study by Johnson, Philip J., Dhanaraj, Sofi, Berhane, Sarah, Bonnett, Laura, Ma, Yuk Ting

“…Background The neutrophil–lymphocyte ratio (NLR), a presumed measure of the balance between neutrophil-associated pro-tumour inflammation and…”
Get full text

Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment by Berhane, Sarah, Fox, Richard, García-Fiñana, Marta, Cucchetti, Alessandro, Johnson, Philip

“…Background Sorafenib is the current standard of care for patients with advanced hepatocellular carcinoma (aHCC) and has been shown to improve survival by about…”
Get full text

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection by Dinnes, Jacqueline, Deeks, Jonathan J, Berhane, Sarah, Taylor, Melissa, Adriano, Ada, Davenport, Clare, Dittrich, Sabine, Emperador, Devy, Takwoingi, Yemisi, Cunningham, Jane, Beese, Sophie, Domen, Julie, Dretzke, Janine, Ferrante di Ruffano, Lavinia, Harris, Isobel M, Price, Malcolm J, Taylor-Phillips, Sian, Hooft, Lotty, Leeflang, Mariska Mg, McInnes, Matthew Df, Spijker, René, Van den Bruel, Ann

“…Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the COVID-19 pandemic…”
Get more information

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis by Best, Jan, Bechmann, Lars P., Sowa, Jan-Peter, Sydor, Svenja, Dechêne, Alexander, Pflanz, Kristina, Bedreli, Sotiria, Schotten, Clemens, Geier, Andreas, Berg, Thomas, Fischer, Janett, Vogel, Arndt, Bantel, Heike, Weinmann, Arndt, Schattenberg, Jörn M., Huber, Yvonne, Wege, Henning, von Felden, Johann, Schulze, Kornelius, Bettinger, Dominik, Thimme, Robert, Sinner, Friedrich, Schütte, Kerstin, Weiss, Karl Heinz, Toyoda, Hidenori, Yasuda, Satoshi, Kumada, Takashi, Berhane, Sarah, Wichert, Marc, Heider, Dominik, Gerken, Guido, Johnson, Philip, Canbay, Ali

“…The prevalence of nonalcoholic steatohepatitis (NASH) associated hepatocellular carcinoma (HCC) is increasing. However, strategies for detection of early-stage…”
Get full text

Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma by Kolamunnage-Dona, Ruwanthi, Berhane, Sarah, Potts, Harry, Williams, Edward H., Tanner, James, Janowitz, Tobias, Hoare, Matthew, Johnson, Philip

“…Sorafenib has been the standard of care for patients with advanced hepatocellular carcinoma and although immunotherapeutic approaches are now challenging this…”
Get full text

International validation of the Chinese University Prognostic Index for staging of hepatocellular carcinoma： a joint United Kingdom and Hong Kong study by Chan, Stephen L, Johnson, Philip J, Mo, Frankie, Berhane, Sarah, Teng, Mabel, Chan, Anthony W H, Poon, Ming C, Lai, Paul B S, Yu, Simon, Chan, Anthony T C, Yeo, Winnie

“…The outcome of hepatocellular carcinoma （HCC） patients significantly differs between western and eastern population centers. Our group previously developed and…”
Get full text